-
The biomedical sector bottomed out, and the agency suggested further increasing allocation
Time of Update: 2022-12-29
In January, the "14th Five-Year Plan" for the development of the pharmaceutical industry was released, the main content of which is to strengthen the research of key core technologies and vigorously promote the research and development of innovative products.
-
Tonghua Dongbao 2 insulin aspart injections were approved, one of which was the first imitation
Time of Update: 2022-11-26
At present, the domestic listed enterprises of insulin aspart 30 injection include Gan&Lee Pharmaceutical, Zhuhai Federal Pharmaceutical, and Yichang Dongguang Changjiang Pharmaceutical in addition to the original research manufacturers and Tonghua Dongbao.
-
THERMOLAST M - Can be overmolded on polyamide
Time of Update: 2022-11-17
Compliant with essential medical certifications such as ISO 10993-5 and -10, the MC/AD/PA series is an ideal material solution for medical grade plastic applications . Features of this range include e
-
The demand for ophthalmic medical treatment continues to grow, and related companies are ushering in a favorable situation
Time of Update: 2022-10-31
In recent years, with the aging of China's population and the widespread use of electronic products, the incidence of eye diseases is continuing to increase, and the scale of the ophthalmic medical market has shown a steady growth trend.
-
The number of people vaccinated with the third dose of the new crown vaccine in Japan accounts for 65.7% of the country's total population
Time of Update: 2022-10-19
According to the Japan Broadcasting Association TV, the latest data released by the Japanese government on the 17th showed that the number of people who completed the third dose of the new crown vaccine in Japan was 82755821, accounting for 65.
-
Why can liver cancer occur without underlying liver disease? Case learning
Time of Update: 2022-10-03
Therefore, HCC may also occur in patients without underlying liver disease, although rare.
Therefore, HCC may also occur in patients without underlying liver disease, although rare.
Therefore, HCC may also occur in patients without underlying liver disease, although rare.
-
The United States may tighten cross-border mergers and acquisitions of pharmaceutical companies, and there will be no winners after the gunshots
Time of Update: 2022-10-02
On September 15, the Biden administration signed a new policy to tighten cross-border biopharmaceutical mergers and acquisitions, requiring the Committee on Foreign Investment in the United States to strengthen risk reviews of biopharmaceuticals and biotechnology.
-
The place issued a document requiring pharmacies to implement "zero-markup" sales of centralized procurement products
Time of Update: 2022-08-20
It is worth mentioning that under the background that Jiangsu Province vigorously promotes pharmacies to implement "zero-markup" sales of centrally-purchased products, the first batch of "medical insurance convenience pharmacies" in Xuzhou has been built recently, and 23 pharmacies have passed the inspection and were officially listed.
-
KRAIBURG TPE TPE meets new guidelines for medical-grade plastics
Time of Update: 2022-08-18
. "VDI 2017 is a very important first step towards unifying the range of properties that medical grade plastics must meet, it provides mandatory communication between medical grade plastic manufacturers and OEMs and/or medical, pharmaceutical and in vitro product manufacturers Guidelines,” said Oliver Kluge, Member of the Guidelines Committee and Consultant for KRAIBURG TPE® Medical Products .
-
Case sharing: Abiraterone has a significant effect of deeply relieving PSA, and the quality of the original drug is better
Time of Update: 2022-04-30
Figure 5 Changes in PSA values of patients during treatment with domestic abiraterone Metastasis, multiple bone metastases throughout the body, and tumor heterogeneity in some lesions, please combine clinical practice .
-
Yuandong Biological Announcement: It plans to invest 245 million yuan to participate in the big health industry fund
Time of Update: 2022-03-06
Yuandong Biology stated in the announcement that the company uses the industry experience, resource advantages and management platform of professional investment institutions to obtain corresponding industry resources and reserves of potential direct bidding; at the same time, it combines the management experience and risk control of fund managers and general partners.
-
The number of domestic PD-(L)1 has reached 12, and it may become a trend to reduce the price to enter the "ordinary people's home
Time of Update: 2022-02-16
In 2021, the K medicine patient assistance project released a new plan: From January 1, 2021, patients only need to pay for 4 courses of treatment and cost 140,000 yuan.
-
Industry: In the fourth quarter, the performance of the pharmaceutical high-prosperity sector is expected to grow rapidly
Time of Update: 2021-11-14
Looking forward to the fourth quarter, the industry believes that the performance of the pharmaceutical high-prosperity sector is expected to grow rapidly, including CXO, medical devices, vaccines, medical services and APIs .
-
The diagnosis and treatment of recurrent dizziness and vertigo is done in one article
Time of Update: 2021-08-08
2 Diagnosis of recurrent dizziness and vertigo Professor Qi Xiaokun introduced that the diagnosis and differential diagnosis of recurrent dizziness and vertigo should consider factors such as the onset of disease, frequency of attacks, duration of symptoms, etc.
-
Another medicine mining alliance is here
Time of Update: 2021-06-22
Medicine Medicine Medicine Medical institutions should give priority to the use of selected drugs, strictly implement the selected prices, and ensure that the agreed purchase volume is completed .
